Vimarsana
Biggest News Aggregation in the World

Page 16 - Systemic Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Sclerosis Today - Breaking & Trending Today

Cantargia AB: Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence - Vimarsana News

Cantargia AB: Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence

LUND, Sweden, Sept. 15, 2022 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating efficacy of its anti-inflammatory IL1RAP-binding

Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence - Vimarsana News

Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence

/PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating efficacy of its anti-inflammatory...

Hematology Oncology Market Destine to Reach USD 14.83 - Vimarsana News

Hematology Oncology Market Destine to Reach USD 14.83

The haematology oncology market is benefited by advantageous reimbursement policies, pharmaceutical industry cooperation, and the rise in healthcare...

Plentisoft: ASK4SAM Launches New York Camp Lejeune Toxic Water Legal Injury Claims Hotline - Vimarsana News

Plentisoft: ASK4SAM Launches New York Camp Lejeune Toxic Water Legal Injury Claims Hotline

Silberstein, Awad, and Miklos, P.C. (ASK4SAM) has recently sponsored a toll free hotline number for New York residents who have been affected by the Camp Lejeune Toxic Water Contamination and who want

Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

Chemomab Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative...